Gene · 9536
Papers2,865
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,865
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent Advances in DMSO-Based Direct Synthesis of Heterocycles. | Molecules | 2022 | 36500564 | PubTator, text mining | PubMed |
| Fibroblast inflammatory priming determines regenerative versus fibrotic skin repair in reindeer. | Cell | 2022 | 36493752 | PubTator, text mining | PubMed |
| Genome-wide differential DNA methylation analysis of MDA-MB-231 breast cancer cells treated with curcumin derivatives, ST08 and ST09. | BMC Genomics | 2022 | 36474139 | PubTator, text mining | PubMed |
| Systems biology network reveals the correlation between COX-2 expression and Ch 7q copy number alterations in Ch 11q-deleted pediatric neuroblastoma tumors. | Genes Cancer | 2022 | 36471782 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis of tumor immune microenvironment characteristics in colorectal cancer liver metastasis. | Ann Transl Med | 2022 | 36467341 | PubTator, text mining | PubMed |
| Blockade of prostaglandin E2 receptor 4 ameliorates peritoneal dialysis-associated peritoneal fibrosis. | Front Pharmacol | 2022 | 36438844 | PubTator, text mining | PubMed |
| Mechanistic Insights into the Neuroprotective Potential of Sacred Ficus Trees. | Nutrients | 2022 | 36432418 | PubTator, text mining | PubMed |
| Targeting Inflammation and Regeneration: Scaffolds, Extracellular Vesicles, and Nanotechnologies as Cell-Free Dual-Target Therapeutic Strategies. | Int J Mol Sci | 2022 | 36430272 | PubTator, text mining | PubMed |
| Role of Arbovirus Infection in Arthritogenic Pain Manifestation-A Systematic Review. | Trop Med Infect Dis | 2022 | 36422941 | PubTator, text mining | PubMed |
| Genome-Wide RNA Sequencing of Human Trabecular Meshwork Cells Treated with TGF-β1: Relevance to Pseudoexfoliation Glaucoma. | Biomolecules | 2022 | 36421707 | PubTator, text mining | PubMed |
| Prostaglandin E2 in neuroblastoma: Targeting synthesis or signaling? | Biomed Pharmacother | 2022 | 36411643 | PubTator, text mining | PubMed |
| Cervical cancer heterogeneity: a constant battle against viruses and drugs. | Biomark Res | 2022 | 36397138 | PubTator, text mining | PubMed |
| Prognostic stratification based on the levels of tumor-infiltrating myeloid-derived suppressor cells and PD-1/PD-L1 axis in locally advanced rectal cancer. | Front Oncol | 2022 | 36387259 | PubTator, text mining | PubMed |
| Primary Hypertrophic Osteoarthropathy With Myelofibrosis. | Cureus | 2022 | 36381760 | PubTator, text mining | PubMed |
| Biosynthesis of prostaglandin 15dPGJ2 -glutathione and 15dPGJ2-cysteine conjugates in macrophages and mast cells via MGST3. | J Lipid Res | 2022 | 36370807 | PubTator, text mining | PubMed |
| Systemic Lipopolysaccharide Challenge Induces Inflammatory Changes in Rat Dorsal Root Ganglia: An Ex Vivo Study. | Int J Mol Sci | 2022 | 36361909 | PubTator, text mining | PubMed |
| YPEL3 Negatively Regulates Endometrial Function via the Wnt/β-Catenin Pathways during Early Pregnancy in Goats. | Animals (Basel) | 2022 | 36359097 | PubTator, text mining | PubMed |
| Involvement of Mitochondrial Dysfunction in the Inflammatory Response in Human Mesothelial Cells from Peritoneal Dialysis Effluent. | Antioxidants (Basel) | 2022 | 36358557 | PubTator, text mining | PubMed |
| Effects of Oleacein, a New Epinutraceutical Bioproduct from Extra Virgin Olive Oil, in LPS-Activated Murine Immune Cells. | Pharmaceuticals (Basel) | 2022 | 36355509 | PubTator, text mining | PubMed |
| Single-cell RNA-seq analysis and cell-cluster deconvolution of the human preovulatory follicular fluid cells provide insights into the pathophysiology of ovarian hyporesponse. | Front Endocrinol (Lausanne) | 2022 | 36339426 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9536/papers?page=20